早期发现癌症:皮肤瘤查的重要性
Laura Stătescu1,2, Elena Cojocaru3, Laura Mihaela Trandafir4
1Department of Dermatology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Cancers
|June 28, 2023
概括
癌症患者的长期管理包括早期诊断和定期检查是否复发. 缺少皮肤癌监测的具体指导方针,需要由医生领导的,基于文献的监测策略.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 公共卫生 公共卫生
背景情况:
- 癌症患者的有效长期管理对于生存和生活质量至关重要.
- 早期诊断和持续监测是管理瘤疾病的关键组成部分.
- 目前关于长期皮肤癌监测的国际指导方针尚未得到充分确立.
研究的目的:
- 概述癌症患者长期管理的基本组成部分.
- 强调需要对皮肤瘤进行标准化的监测协议.
- 强调医生经验和文献数据在管理高风险皮肤病变患者中的作用.
主要方法:
- 审查欧洲医学瘤学会专家建议.
- 分析关于长期监测皮肤新生瘤的现有文献.
- 讨论早期诊断,复发检测和患者教育的策略.
主要成果:
- 长期的癌症患者管理包括通过查和定期随访进行早期诊断.
- 对于监测非黑色素瘤皮肤癌,恶性黑色素瘤或高风险癌前病变,目前还没有普遍的国际指导方针.
- 可以根据医生的专业知识和文献数据建立监测间隔.
结论:
- 综合性癌症护理需要强大的长期管理策略.
- 制定皮肤癌监测的具体指南是有必要的.
- 在医生指导下,基于证据的监测对于高风险的皮肤瘤患者至关重要.
相关概念视频
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Preventive Healthcare Services
1.1K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.1K
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Cancers Originate from Somatic Mutations in a Single Cell
12.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.1K


